晶瑞電材(300655.SZ):輔沅合夥的最終投資標的為自動駕駛的獨角獸企業文遠知行
格隆匯8月17日丨有投資者向晶瑞電材(300655.SZ)提問,“請問公司有無無人駕駛技術或參股公司有無人駕駛技術?”
晶瑞電材回覆稱,公司全資子公司善豐投資(江蘇)有限公司與馬鞍山基石浦江資產管理有限公司及相關自然人共同以現金方式出資投資成立福州市輔沅投資合夥企業(有限合夥),輔沅合夥為特定投資目的的專項基金(SPV),該專項基金的最終投資標的為自動駕駛的獨角獸企業廣州文遠知行科技有限公司,文遠知行擁有一整套無人駕駛技術。可詳見公司於2021年1月20日披露的《關於對外投資暨關聯交易的公吿》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.